Parkinson's disease (PD) is a debilitating and progressive neurodegenerative disorder caused by the loss of ...

The Orissa High Court has held that a writ petition seeking deletion of deceased person's name from Record of Rights (RoR) ...

Ocugen has announced the publication of positive results from its phase 1 GARDian1 trial of OCU410ST, a gene therapy for ...

A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the ...

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum ...

The FDA has approved Zycubo (copper histidinate) injection as the first and only treatment of Menkes disease in pediatric patients.

A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and difficult-to-treat form of lung cancer. The study shows that a combination of ...

A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and difficult-to-treat form of lung cancer.

Tessera Therapeutics, the biotechnology company pioneering a new approach in genetic medicine known as Gene Writing™, today announced that the U.S. Food and Drug Administration (FDA) has cleared its ...

Fund is collected in the name of public interest. In practice, a substantial portion of the money ends up financing private ...

A successful Phase 3 trial and a public offeringof stock boosted prospects for this company to receive approval for an ...